• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13D/A filed by HighCape Capital Acquisition Corp. (Amendment)

    6/14/21 5:18:16 PM ET
    $CAPA
    Business Services
    Finance
    Get the next $CAPA alert in real time by email
    SC 13D/A 1 e620719_sc13da-highcape.htm

     

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    SCHEDULE 13D

    [Rule 13d-101]

     

    INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 24.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13D-2(a)

     

    (Amendment No. 2)*

     

    HighCape Capital Acquisition Corp.

    (Name of Issuer)

     

    Class A common stock, par value $0.0001 per share

    (Title of Class of Securities)

     

    42984L204

    (CUSIP Number)

     

    David Clark

    Elliot Press

    Deerfield Management Company, L.P.

    345 Park Avenue South, 12th Floor

    New York, New York 10010

    (212) 551-1600

     

    With a copy to:

     

    Jonathan D Weiner, Esq.

    Mark D. Wood, Esq.

    Katten Muchin Rosenman LLP

    575 Madison Avenue

    New York, New York 10022

    (212) 940-8800

     

    (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

     

    June 10, 2021

    (Date of Event which Requires Filing of this Statement)

     

    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box ☐.

     

    Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See § 240.13d-7 for other parties to whom copies are to be sent.

     

    (Continued on following pages)

    (Page 1 of 9 Pages)

     

    * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

     

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

         

     

     

      

    SCHEDULE 13D

    CUSIP No.  42984L204 Page 2 of 9 Pages

     

    1

    NAME OF REPORTING PERSONS

     

    Deerfield Mgmt, L.P.

     
    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     

     

    (a) ☐

    (b) ☒

     

    3

    SEC USE ONLY

     

     

     
    4

    SOURCE OF FUNDS

     

    AF

     
    5

    CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)

     

     

    ☐
    6

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Delaware

     

     

     

     NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

    7

    SOLE VOTING POWER

     

    0

     
    8

    SHARED VOTING POWER

     

    1,400,000 (1)

     

    9

     

    SOLE DISPOSITIVE POWER

     

    0

     

    10

     

    SHARED DISPOSITIVE POWER

     

    1,400,000 (1)

     

    11

     

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    1,400,000 (1)

     
    12

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*

     

     

    ☐ 

    13

     

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     

    1.69%

     
    14

    TYPE OF REPORTING PERSON

     

    PN

     

     

    (1) Does not include 333,333 shares of Class A common stock issuable upon exercise of warrants held by Deerfield Partners, L.P., which warrants are not presently exercisable and are not exercisable within 60 days from the date hereof.

        

     

     

     

    SCHEDULE 13D

    CUSIP No.  42984L204 Page 3 of 9 Pages

     

    1

    NAME OF REPORTING PERSONS

     

    Deerfield Partners, L.P.

     
    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     

     

    (a) ☐

    (b) ☒

     

    3

    SEC USE ONLY

     

     

     
    4

    SOURCE OF FUNDS

     

    WC

     
    5

    CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)

     

     

    ☐
    6

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Delaware

     

     

     

     NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

    7

    SOLE VOTING POWER

     

    0

     
    8

    SHARED VOTING POWER

     

    1,400,000 (2)

     

    9

     

    SOLE DISPOSITIVE POWER

     

    0

     

    10

     

    SHARED DISPOSITIVE POWER

     

    1,400,000 (2)

     

    11

     

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    1,400,000 (2)

     
    12

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*

     

     

    ☐ 

    13

     

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     

    1.69%

     
    14

    TYPE OF REPORTING PERSON

     

    PN

     

     

    (2) Does not include 333,333 shares of Class A common stock issuable upon exercise of warrants held by Deerfield Partners, L.P., which warrants are not presently exercisable and are not exercisable within 60 days from the date hereof.

        

     

     

     

    SCHEDULE 13D

    CUSIP No.  42984L204 Page 4 of 9 Pages

     

    1

    NAME OF REPORTING PERSONS

     

    Deerfield Management Company, L.P.

     
    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     

     

    (a) ☐

    (b) ☒

     

    3

    SEC USE ONLY

     

     

     
    4

    SOURCE OF FUNDS

     

    AF

     
    5

    CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)

     

     

    ☒
    6

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Delaware

     

     

     

     NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

    7

    SOLE VOTING POWER

     

    0

     
    8

    SHARED VOTING POWER

     

    1,400,000 (3)

     

    9

     

    SOLE DISPOSITIVE POWER

     

    0

     

    10

     

    SHARED DISPOSITIVE POWER

     

    1,400,000 (3)

     

    11

     

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    1,400,000 (3)

     
    12

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*

     

     

    ☐ 

    13

     

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     

    1.69%

     
    14

    TYPE OF REPORTING PERSON

     

    PN

     

     

    (3) Does not include 333,333 shares of Class A common stock issuable upon exercise of warrants held by Deerfield Partners, L.P., which warrants are not presently exercisable and are not exercisable within 60 days from the date hereof.

        

     

     

      

    SCHEDULE 13D

    CUSIP No.  42984L204 Page 5 of 9 Pages

     

    1

    NAME OF REPORTING PERSONS

     

    James E. Flynn

     
    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     

     

    (a) ☐

    (b) ☒

     

    3

    SEC USE ONLY

     

     

     
    4

    SOURCE OF FUNDS

     

    AF

     
    5

    CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)

     

     

    ☐
    6

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    United States of America

     

     

     

     NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

    7

    SOLE VOTING POWER

     

    0

     
    8

    SHARED VOTING POWER

     

    1,400,000 (4)

     

    9

     

    SOLE DISPOSITIVE POWER

     

    0

     

    10

     

    SHARED DISPOSITIVE POWER

     

    1,400,000 (4)

     

    11

     

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    1,400,000 (4)

     
    12

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*

     

     

    ☐ 

    13

     

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     

    1.69%

     
    14

    TYPE OF REPORTING PERSON

     

    IN

     

     

    (4) Does not include 333,333 shares of Class A common stock issuable upon exercise of warrants held by Deerfield Partners, L.P., which warrants are not presently exercisable and are not exercisable within 60 days from the date hereof.

         

     

     

     

    CUSIP No.  42984L204 6 of 9 Pages

     

    This Amendment No. 2 (this “Amendment”) to Schedule 13D amends the Schedule 13D filed by (i) Deerfield Mgmt, L.P. (“Deerfield Mgmt”), (ii) Deerfield Partners, L.P. (“Deerfield Partners”), (iii) Deerfield Management Company, L.P. (“Deerfield Management”) and (iv) James E. Flynn, a natural person (“Flynn” and, collectively with Deerfield Mgmt, Deerfield Partners and Deerfield Management, the “Reporting Persons”), with respect to the Class A common stock (the “Class A Common Stock”) of HighCape Capital Acquisition Corp. (the “Company”), as amended by Amendment No. 1 thereto (as previously amended, the “Schedule 13D”).

     

    Item 2.Identity and Background.

     

    Items 2(b) and 2(c) of the Schedule 13D are hereby amended and restated in their entirety to read as follows:

     

    (b)The address of the principal business and/or principal office of each Reporting Person is 345 Park Avenue South, 12th Floor, New York, New York 10010.

     

    (b)Flynn is the managing member of the general partner of each of Deerfield Mgmt and Deerfield Management. Deerfield Mgmt is the general partner, and Deerfield Management is the investment manager, of Deerfield Partners. Deerfield Partners purchases, holds and sells securities and other investment products. Schedule A hereto sets forth information regarding persons referred in Instruction C to Schedule 13D.

     

    Item 3.Source and Amount of Funds or Other Consideration.

     

    Item 3 of the Schedule 13D is hereby amended to add the following:

     

    On June 10, 2021, Deerfield Partners purchased the 400,000 Deerfield PIPE Shares immediately prior to the closing of the BC Transactions at a price of $10.00 per share, for aggregate gross proceeds of $4,000,000. Deerfield Partners utilized available cash assets to acquire the Deerfield PIPE Shares.

     

    Additionally, as a result of the consummation of the BC Transactions, warrants held by Deerfield Partners that entitle the holder thereof to purchase an aggregate of 333,333 shares of Class A common stock, will become exercisable on September 9, 2021.

     

    Item 4.Purpose of Transaction.

     

    Item 4 of the Schedule 13D is hereby amended to add the following:

     

    As previously announced by the issuer, on June 10, 2021, the Issuer consummated the BC Transactions pursuant to the terms of the Business Combination Agreement as well as the PIPE Transactions. As previously disclosed in the Schedule 13D, the purpose of Deerfield Partners’ purchase of the Deerfield PIPE Shares was to provide capital to the Company (together with funds in the Company’s trust account not subject to redemptions) in connection with the BC Transactions.

     

     

     

     

    CUSIP No.  42984L204 7 of 9 Pages

     

    Item 5.Interest in Securities of the Issuer.

     

    Items 5(a), 5(b), 5(c) and 5(e) of the Schedule 13D are hereby amended and restated in their entirety to read as follows:

     

    (a)        

     

    (1)      Deerfield Mgmt

     

    Number of shares: 1,400,000 (comprised of shares held by Deerfield Partners)

    Percentage of shares: 1.69%*

     

    (2)      Deerfield Management

     

    Number of shares: 1,400,000 (comprised of shares held by Deerfield Partners) 

    Percentage of shares: 1.69%*

     

    (3)      Deerfield Partners

     

    Number of shares: 1,400,000

    Percentage of shares: 1.69%*

     

    (4)      Flynn

     

    Number of shares: 1,400,000 (comprised of shares held by Deerfield Partners)

    Percentage of shares: 1.69%*

     

    *Reflects 82,660,175 shares of Class A common stock outstanding as of June 10, 2021, based on information provided by the Issuer.

     

    (b)       

     

    (1)      Deerfield Mgmt

     

    Sole power to vote or direct the vote: 0

    Shared power to vote or direct the vote: 1,400,000

    Sole power to dispose or to direct the disposition: 0

    Shared power to dispose or direct the disposition: 1,400,000

     

    (2)      Deerfield Management

     

    Sole power to vote or direct the vote: 0

    Shared power to vote or direct the vote: 1,400,000

    Sole power to dispose or to direct the disposition: 0

    Shared power to dispose or direct the disposition: 1,400,000

     

     

     

     

    CUSIP No.  42984L204 8 of 9 Pages

     

    (3)      Deerfield Partners

     

    Sole power to vote or direct the vote: 0

    Shared power to vote or direct the vote: 1,400,000

    Sole power to dispose or to direct the disposition: 0

    Shared power to dispose or direct the disposition: 1,400,000

     

    (4)      Flynn

     

    Sole power to vote or direct the vote: 0

    Shared power to vote or direct the vote: 1,400,000

    Sole power to dispose or to direct the disposition: 0

    Shared power to dispose or direct the disposition: 1,400,000

     

    Flynn is the managing member of the general partner of each of Deerfield Mgmt and Deerfield Management. Deerfield Mgmt is the general partner, and Deerfield Management is the investment manager, of Deerfield Partners.

     

    (e) On June 10, 2021, the Reporting Persons ceased to beneficially own more than five percent of the Class A Common Stock.

     

     

     

     

    CUSIP No.  42984L204 9 of 9 Pages

     

    SIGNATURE

     

    After reasonable inquiry and to the best of their knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct.

     


    Dated: June 14, 2021

     

      DEERFIELD MGMT, L.P.
      By: J.E. Flynn Capital, LLC, General Partner
         
      By: /s/ Jonathan Isler
      Name:   Jonathan Isler
      Title:   Attorney-in-Fact    
         
      DEERFIELD PARTNERS, L.P.
      By: Deerfield Mgmt, L.P., General Partner
      By: J.E. Flynn Capital, LLC, General Partner
         
      By: /s/ Jonathan Isler
      Name:   Jonathan Isler   
      Title:   Attorney-in-Fact    
         
         
      DEERFIELD MANAGEMENT COMPANY, L.P.
      By:  Flynn Management LLC, General Partner
         
      By: /s/ Jonathan Isler
      Name:   Jonathan Isler   
      Title:   Attorney-in-Fact     
         
         
      JAMES E. FLYNN
         
       /s/ Jonathan Isler
      Jonathan Isler, Attorney-in-Fact

     

     

     

     

    Schedule A

     

    General Partner of Deerfield Mgmt, L.P.

     

    The general partner of Deerfield Mgmt is J.E. Flynn Capital, LLC. The address of the principal business and/or principal office of Deerfield Mgmt and J.E. Flynn Capital, LLC is 345 Park Avenue South, 12th Floor, New York, New York 10010.

     

    General Partner of Deerfield Partners, L.P.

     

    The general partner of Deerfield Partners is Deerfield Mgmt. The address of the principal business and/or principal office of Deerfield Mgmt and Deerfield Partners is 345 Park Avenue South, 12th Floor, New York, New York 10010.

     

    General Partner of Deerfield Management Company, L.P.

     

    The general partner of Deerfield Management is Flynn Management LLC. The address of the principal business and/or principal office of Deerfield Management and Flynn Management LLC is 345 Park Avenue South, 12th Floor, New York, New York 10010.

     

    Get the next $CAPA alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CAPA

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $CAPA
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Issuer Direct Announces New Board of Directors to Support Next Chapter of Growth

      RALEIGH, NC / ACCESSWIRE / July 1, 2024 / Issuer Direct Corporation (NYSE:ISDR), an industry-leading communications company, today announced it has appointed Wes Pollard and Joe Staples as new independent members of its Board of Directors."We are excited to welcome Wes and Joe to the Issuer Direct Board of Directors," said CEO Brian Balbirnie. "We believe their respective skillsets are an ideal fit for us as we pursue our strategic vision to be a leading provider of media and communications software to the PR (Public Relations) and IR (Investor Relations) industry. We are confident they will be valuable additions to our company as we continue to optimize our business and work to maximize val

      7/1/24 10:45:00 AM ET
      $ISDR
      $CAPA
      Publishing
      Consumer Discretionary
      Business Services
      Finance
    • Quantum-Si Announces Expansion of Early Access Program for the Platinum™ Single Molecule Protein Sequencing Platform

      Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), a life science tools company commercializing a unique protein sequencing platform, announced today that they have expanded their Platinum early access program to ten sites, with participation from leading academic centers and key industry partners. The early access program introduces the Platinum single molecule sequencing system to key opinion leaders across the globe, for both expansion and development of applications and workflows. "The Company is experiencing tremendous momentum and demand for participation in our early access program to analyze previously unapproachable levels of biological understanding of t

      10/19/21 4:15:00 PM ET
      $CAPA
      $QSI
      Business Services
      Finance
      Industrial Machinery/Components
      Industrials
    • Quantum-Si Incorporated to Participate in the 2021 Cantor Fitzgerald Virtual Global Healthcare Conference

      Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si" or the "Company"), a company pioneering next-generation semiconductor chip-based proteomics, today announced its participation in the Cantor Fitzgerald Virtual Global Healthcare Conference which takes place September 27-30, 2021. John Stark, Quantum-Si's Chief Executive Officer, and Claudia Drayton, Chief Financial Officer, will participate in a virtual fireside chat on Wednesday, September 29, at 1:20 – 1:50 pm EDT. Please visit the Investor Relations section of the Quantum-Si website here to view the Company's most recent corporate presentation. About Quantum-Si Incorporated Founded by Dr. Jonathan Rothberg in 2013, Quantum-Si is focus

      9/21/21 4:15:00 PM ET
      $CAPA
      $QSI
      Business Services
      Finance
      Industrial Machinery/Components
      Industrials

    $CAPA
    Leadership Updates

    Live Leadership Updates

    See more
    • Quantum-Si Strengthens Board of Directors With Two Key Appointments

      Quantum-Si Incorporated, a company pioneering next-generation semiconductor chip-based proteomics, announced today the appointment of Marijn Dekkers, Ph.D. and Ruth Fattori to its Board of Directors. Both Dr. Dekkers and Ms. Fattori have agreed to continue to serve on the Board of Directors of the combined company subsequent to the closing of the previously announced business combination between Quantum-Si and HighCape Capital Acquisition Corp (NASDAQ:CAPA). "We are positioning Quantum-Si to have the best chance of delivering on the promise of next-generation proteomics by continuing to enhance our leadership team and board of directors, including the addition of Dr. Marijn Dekkers, former

      5/6/21 8:00:00 AM ET
      $CAPA
      Business Services
      Finance
    • Quantum-Si Appoints Dr. Michael Mina as Chief Medical Advisor

      Quantum-Si Incorporated, a company pioneering next-generation semiconductor chip-based proteomics, announced today the appointment of Michael Mina, M.D., Ph.D., Assistant Professor of Epidemiology, Immunology, Infectious Diseases and Pathology at the Harvard T.H. Chan School of Public Health and Harvard Medical School, as Chief Medical Advisor for the company. "As we create the next generation of protein sequencing and proteomics to transform how we study and diagnose disease, moving from the analog to the digital world and allowing a level of sensitivity, precision and understanding never before possible, Dr. Mina's expertise will be invaluable in guiding Quantum-Si's application efforts,

      4/29/21 8:00:00 AM ET
      $CAPA
      Business Services
      Finance

    $CAPA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4: RAKIN KEVIN was granted 1,921,512 units of Class A Common Stock

      4 - Quantum-Si Inc (0001816431) (Issuer)

      6/15/21 5:27:21 PM ET
      $CAPA
      Business Services
      Finance
    • SEC Form 4: ROTHBERG JONATHAN M was granted 17,213,479 units of Class A Common Stock and was granted 19,937,500 units of Class B Common Stock

      4 - Quantum-Si Inc (0001816431) (Issuer)

      6/14/21 6:56:10 PM ET
      $CAPA
      Business Services
      Finance
    • SEC Form 4: Makes Brigid was granted 20,512 units of Class A Common Stock

      4 - Quantum-Si Inc (0001816431) (Issuer)

      6/14/21 6:56:44 PM ET
      $CAPA
      Business Services
      Finance

    $CAPA
    Financials

    Live finance-specific insights

    See more
    • Quantum-Si Reports Second Quarter 2021 Financial Results

      Quantum-Si Solidifies Financial Strength and Continues Systematic Commercialization Strategy Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si" or the "Company"), a company pioneering next-generation semiconductor chip-based proteomics, today announced financial results for the quarter ended June 30, 2021 and provided a business update. John Stark, Quantum-Si's Chief Executive Officer, and Claudia Drayton, Quantum-Si's Chief Financial Officer, will host a call today at 4:30 pm EDT to review the Company's results. Recent Highlights: Completed the business combination with HighCape Capital Acquisition Corp. ("HighCape"), adding over $511 million in cash to the balance sheet. Successfull

      8/16/21 4:05:00 PM ET
      $CAPA
      $QSI
      Business Services
      Finance
      Industrial Machinery/Components
      Industrials
    • Quantum-Si to Report Second Quarter 2021 Financial Results on August 16, 2021

      Quantum-Si Incorporated, a company pioneering next-generation semiconductor chip-based proteomics, today announced that it has rescheduled its conference call to report second quarter 2021 financial results to August 16, 2021, after market close. John Stark, Chief Executive Officer, and Claudia Drayton, Chief Financial Officer, will host a conference call and webcast at 4:30 p.m. ET on August 16, 2021, to discuss second quarter 2021 financial results and provide a business update. The conference call will be broadcast live in listen-only mode via a webcast on Quantum-Si's Investor Relations website at Events & Presentations. Individuals interested in listening to the conference call on y

      8/11/21 7:00:00 AM ET
      $CAPA
      $QSI
      Business Services
      Finance
      Industrial Machinery/Components
      Industrials

    $CAPA
    SEC Filings

    See more
    • HighCape Capital Acquisition Corp. filed SEC Form 8-K: Leadership Update

      8-K - Quantum-Si Inc (0001816431) (Filer)

      7/6/21 6:52:38 AM ET
      $CAPA
      Business Services
      Finance
    • SEC Form S-1 filed by HighCape Capital Acquisition Corp.

      S-1 - Quantum-Si Inc (0001816431) (Filer)

      7/2/21 5:00:18 PM ET
      $CAPA
      Business Services
      Finance
    • HighCape Capital Acquisition Corp. filed SEC Form 8-K: Leadership Update

      8-K - Quantum-Si Inc (0001816431) (Filer)

      6/25/21 4:37:54 PM ET
      $CAPA
      Business Services
      Finance

    $CAPA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13D filed by HighCape Capital Acquisition Corp.

      SC 13D - Quantum-Si Inc (0001816431) (Subject)

      6/21/21 5:20:40 PM ET
      $CAPA
      Business Services
      Finance
    • SEC Form SC 13D filed by HighCape Capital Acquisition Corp.

      SC 13D - Quantum-Si Inc (0001816431) (Subject)

      6/21/21 3:37:21 PM ET
      $CAPA
      Business Services
      Finance
    • SEC Form SC 13D/A filed by HighCape Capital Acquisition Corp. (Amendment)

      SC 13D/A - Quantum-Si Inc (0001816431) (Subject)

      6/14/21 5:18:16 PM ET
      $CAPA
      Business Services
      Finance